In a significant advancement for spinal health technology, Aurora Spine Corporation has been awarded its second US patent for innovative spine treatment implants, designed to harmonize with individual bone density measures. Patent number 11,850,162 marks the company’s continued commitment to developing tailored solutions in the field of orthopedics.
The patented DEXA Technology employs a DEXA Scan to establish a patient’s T-score, which informs the customization of orthopedic implants according to the specific bone density, enhancing bone growth potential and ensuring biomechanical support and integrity. This approach optimizes the bone fusion process, aiming to enhance patient care significantly.
Aurora Spine introduced its premier DEXA Technology-based product, the DEXA-C interbody spacer line, in 2022 to facilitate anterior cervical fusion. Clinicians have positively received the product for its contribution to personalized patient care, leading to its recognition with the 2022 Best New Spine Technology Award.
The acquisition of this latest patent fortifies Aurora Spine’s intellectual property repertoire, reflecting an enduring dedication to overcoming obstacles faced by surgeons, particularly those related to osteoporosis in spinal procedures. With consistent strides in medical innovation, Aurora Spine remains focused on advancing outcomes for patients and reshaping the future of spinal surgery.